The genetic basis of the polycystic ovary syndrome: A literature review including discussion of PPAR-γ

PPAR Research

Volumn , Issue , 2007, Pages

  Unluturk, Ugur ^a   Harmanci, Ayla ^a   Kocaefe, Cetin ^a   Yildiz, Bulent O ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANDROGEN RECEPTOR; AROMATASE; CALPAIN 10; CYTOCHROME P450; CYTOCHROME P450 11A; CYTOCHROME P450 17; FOLLISTATIN; GONADOTROPIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; LEPTIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SEX HORMONE BINDING GLOBULIN; STEROID 21 MONOOXYGENASE; STEROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADRENAL GLAND; CHRONIC INFLAMMATION; CLUSTER ANALYSIS; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; EVOLUTIONARY ADAPTATION; FAMILIAL DISEASE; GENDER; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; INHERITANCE; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; REPRODUCTION; REVIEW; STEROIDOGENESIS;

EID: 42749101427     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2007/49109     Document Type: Review

References (214)

1. R. Azziz azzizr@cshs.org K. S. Woods R. Reyna T. J. Key E. S. Knochenhauer B. O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 89 6 2004 2745 2749
2. J. K. Zawadzki A. Dunaif A. Dunaif J. Givens F. Haseltine G. R. Merriam Diagnostic criteria for polycystic ovary syndrome. Polycystic Ovary Syndrome Blackwell Scientific Boston, Mass, USA 1992 377 384
3. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81 1 2004 19 25
4. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction 19 1 2004 41 47
5. F. Ovalle R. Azziz Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertility and Sterility 77 6 2002 1095 1105
6. R. S. Legro rsl1@psu.edu Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Reviews 24 3 2003 302 312
7. P. Hardiman hardiman@rfc.ucl.ac.uk O. S. Pillay W. Atiomo Polycystic ovary syndrome and endometrial carcinoma. Lancet 361 9371 2003 1810 1812
8. H. E. Cooper W. N. Spellacy K. A. Prem W. D. Cohen Hereditary factors in the Stein-Leventhal syndrome. American Journal of Obstetrics and Gynecology 100 3 1968 371 387
9. R. S. Wilroy Jr. J. R. Givens W. L. Wiser S. A. Coleman R. N. Andersen R. L. Summitt Hyperthecosis: an inheritable form of polycystic ovarian disease. Birth Defects: Original Article Series 11 4 1975 81 85
10. J. R. Givens Familial polycystic ovarian disease. Endocrinology and Metabolism Clinics of North America 17 4 1988 771 783
11. D. Ferriman A. W. Purdie The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clinical Endocrinology 11 3 1979 291 300
12. O. Lunde P. Magnus L. Sandvik S. Hoglo Familial clustering in the polycystic ovarian syndrome. Gynecologic and Obstetric Investigation 28 1 1989 23 30
13. W. M. Hague J. Adams S. T. Reeders T. E. A. Peto H. S. Jacobs Familial polycystic ovaries: a genetic disease? Clinical Endocrinology 29 6 1988 593 605
14. A. H. Carey K. L. Chan F. Short D. White R. Williamson S. Franks Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clinical Endocrinology 38 6 1993 653 658
15. R. J. Norman S. Masters W. Hague Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertility and Sterility 66 6 1996 942 947
16. S. Colilla N. J. Cox D. A. Ehrmann dehrmann@medicine.bsd.uchicago.edu Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. Journal of Clinical Endocrinology and Metabolism 86 5 2001 2027 2031
17. R. S. Legro D. Driscoll J. F. Strauss III J. Fox A. Dunaif adunaif@bics.bwh.harvard.edu Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proceedings of the National Academy of Sciences of the United States of America 95 25 1998 14956 14960
18. R. S. Legro R. Bentley-Lewis D. Driscoll S. C. Wang A. Dunaif Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. Journal of Clinical Endocrinology and Metabolism 87 5 2002 2128 2133
19. R. S. Legro A. R. Kunselman L. Demers S. C. Wang R. Bentley-Lewis A. Dunaif Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 5 2002 2134 2138
20. M. D. Kahsar-Miller C. Nixon L. R. Boots R. C. Go R. Azziz Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility 75 1 2001 53 58
21. B. O. Yildiz yildizbo@yahoo.com H. Yarali H. Oguz M. Bayraktar Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88 5 2003 2031 2036
22. S. Franks N. Gharani D. Waterworth The genetic basis of polycystic ovary syndrome. Human Reproduction 12 12 1997 2641 2648
23. S. Jahanfar J. A. Eden Genetic and non-genetic theories on the etiology of polycystic ovary syndrome. Gynecological Endocrinology 10 5 1996 357 364
24. A. Govind M. S. Obhrai R. N. Clayton Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. Journal of Clinical Endocrinology and Metabolism 84 1 1999 38 43
25. R. E. March Gene mapping by linkage and association analysis. Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology 13 2 1999 113 122
26. L. J. Palmer lyle.palmer@cyllene.uwa.edu.au L. R. Cardon Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 366 9492 2005 1223 1234
27. G. McVean C. C. Spencer R. Chaix Perspectives on human genetic variation from the HapMap Project. PLoS Genetics 1 4 2005 e54
28. S. Franks C. Gilling-Smith N. Gharani M. McCarthy Pathogenesis of polycystic ovary syndrome: evidence for a genetically determined disorder of ovarian androgen production. Human Fertility 3 2 2000 77 79
29. N. Gharani D. M. Waterworth S. Batty Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Human Molecular Genetics 6 3 1997 397 402
30. E. Diamanti-Kandarakis M. I. Bartzis A. T. Bergiele T. C. Tsianateli C. R. Kouli Microsatellite polymorphism (tttta)n at -528 base pairs of gene CYP11α influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertility and Sterility 73 4 2000 735 741
31. Y. Wang X.-K. Wu xiaokewu@nju.edu.cn Y.-X. Cao Microsatellite polymorphism of (tttta)n in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi 85 48 2005 3396 3400
32. M. Gaasenbeek B. L. Powell U. Sovio Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. Journal of Clinical Endocrinology and Metabolism 89 5 2004 2408 2413
33. L. Tan G. Zhu Relationship between the microsatellite polymorphism of CYP11α gene and the pathogenesis of hyperandrogenism of polycystic ovary syndrome in Chinese. Chinese Journal of Medical Genetics 22 2 2005 216 218
34. L. Tan G. Zhu Role of the pentanucleotide (tttta)n polymorphisms of Cyp11alpha gene in the pathogenesis of hyperandrogenism in Chinese women with polycystic ovary syndrome. Journal of Huazhong University of Science and Technology. Medical Sciences 25 2 2005 212 214
35. M. Urbanek R. S. Legro D. A. Driscoll Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proceedings of the National Academy of Sciences of the United States of America 96 15 1999 8573 8578
36. J. L. San Millán J. Sancho R. M. Calvo H. F. Escobar-Morreale Role of the pentanucleotide (tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertility and Sterility 75 4 2001 797 802
37. H. Escobar-Morreale F. Pazos N. Potau R. Garcia-Robles J. M. Sancho C. Varela Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17α Fertility and Sterility 62 3 1994 521 530
38. R. Azziz E. L. Bradley Jr. H. D. Potter L. R. Boots Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. Journal of Clinical Endocrinology and Metabolism 80 2 1995 400 405
39. S. F. Witchel C. E. Aston The role of heterozygosity for CYP21 in the polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism 13, supplement 5 2000 1315 1317
40. S. F. Witchel sfs@med.pitt.edu P. A. Lee M. Suda-Hartman E. P. Hoffman Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochemical and Molecular Medicine 62 2 1997 151 158
41. H. F. Escobar-Morreale hector.escobar@uam.es J. L. San Millán R. R. Smith J. Sancho S. F. Witchel The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertility and Sterility 72 4 1999 629 638
42. D. Glintborg dorte.glintborg@ouh.fyns-amt.dk A. P. Hermann K. Brusgaard J. Hangaard C. Hagen M. Andersen Significantly higher adrenocorticotropin- stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls. Journal of Clinical Endocrinology and Metabolism 90 3 2005 1347 1353
43. S. F. Witchel selma.witchel@chp.edu M. Kahsar-Miller C. E. Aston C. White R. Azziz Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertility and Sterility 83 2 2005 371 375
44. J. Picado-Leonard W. L. Miller Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 6 5 1987 439 448
45. L. Sharp linda.sharp@ncri.ie A. H. Cardy S. C. Cotton J. Little CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. A HuGE review. American Journal of Epidemiology 160 8 2004 729 740
46. R. L. Rosenfield R. B. Barnes J. F. Cara A. W. Lucky Dysregulation of cytochrome P450c 17α as the cause of polycystic ovarian syndrome. Fertility and Sterility 53 5 1990 785 791
47. R. L. Rosenfield R. B. Barnes D. A. Ehrmann Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 79 6 1994 1686 1692
48. H. F. Escobar-Morreale hescobar@mvax.fmed.uam.es J. Serrano-Gotarredona R. García-Robles J. M. Sancho C. Varela Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism. Fertility and Sterility 67 4 1997 654 662
49. J. K. Wickenheisser P. G. Quinn V. L. Nelson R. S. Legro J. F. Strauss III J. M. McAllister Differential activity of the cytochrome P450 17α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. Journal of Clinical Endocrinology and Metabolism 85 6 2000 2304 2311
50. J. K. Wickenheisser V. L. Nelson-Degrave P. G. Quinn J. M. McAllister jmcallister@psu.edu Increased cytochrorne P450 17α-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1. Molecular Endocrinology 18 3 2004 588 605
51. J. K. Wickenheisser V. L. Nelson-DeGrave J. M. McAllister jmcallister@psu.edu Dysregulation of cytochrome P450 17α-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 90 3 2005 1720 1727
52. A. H. Carey D. Waterworth K. Patel Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Human Molecular Genetics 3 10 1994 1873 1876
53. E. Diamanti-Kandarakis M. I. Bartzis E. D. Zapanti Polymorphism T → C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertility and Sterility 71 3 1999 431 435
54. N. Gharani D. M. Waterworth R. Williamson S. Franks 5′ polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 81 11 1996 4174
55. K. Techatraisak G. S. Conway G. Rumsby Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states. Clinical Endocrinology 46 2 1997 131 134
56. S. F. Witchel P. A. Lee M. Suda-Hartman R. Smith E. P. Hoffman 17α-hydroxylase/17,20-lyase dysregulation is not caused by mutations in the coding regions of CYP17. Journal of Pediatric and Adolescent Gynecology 11 3 1998 133 137
57. B. Marszalek M. Laciński N. Babych Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome. Gynecological Endocrinology 15 2 2001 123 128
58. M. Kahsar-Miller L. R. Boots A. Bartolucci R. Azziz azzizr@cshs.org Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. Fertility and Sterility 82 4 2004 973 975
59. L.-H. Zhang H. Rodriguez S. Ohno W. L. Miller Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proceedings of the National Academy of Sciences of the United States of America 92 23 1995 10619 10623
60. K.-N. Qin R. L. Rosenfield robros@peds.bsd.uchicago.edu Role of cytochrome P450c17 in polycystic ovary syndrome. Molecular and Cellular Endocrinology 145 1-2 1998 111 121
61. S. Takayama M. F. White C. R. Kahn Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. Journal of Biological Chemistry 263 7 1988 3440 3447
62. J. E. Chin M. Dickens J. M. Tavare R. A. Roth Overexpression of protein kinase C isoenzymes α, βI, γ, and ε in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. Journal of Biological Chemistry 268 9 1993 6338 6347
63. A. Dunaif J. Xia C.-B. Book E. Schenker Z. Tang Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. Journal of Clinical Investigation 96 2 1995 801 810
64. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18 6 1997 774 800
65. E. R. Simpson M. S. Mahendroo G. D. Means Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews 15 3 1994 342 355
66. D. W. Nebert M. Adesnik M. J. Coon The P450 gene superfamily: recommended nomenclature. DNA 6 1 1987 1 11
67. S. Chen M. J. Besman R. S. Sparkes Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA 7 1 1988 27 38
68. N. Harada H. Ogawa M. Shozu K. Yamada Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. American Journal of Human Genetics 51 3 1992 666 672
69. Y. Ito C. R. Fisher F. A. Conte M. M. Grumbach E. R. Simpson Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proceedings of the National Academy of Sciences of the United States of America 90 24 1993 11673 11677
70. K. Takayama T. Fukaya H. Sasano Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Human Reproduction 11 7 1996 1387 1392
71. G. F. Erickson A. J. W. Hsueh M. E. Quigley R. W. Rebar S. S. Yen Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 49 4 1979 514 519
72. A. J. Jakimiuk S. R. Weitsman P. R. Brzechffa D. A. Magoffin Aromatase mRNA expression in individual follicles from polycystic ovaries. Molecular Human Reproduction 4 1 1998 1 8
73. D. Söderlund P. Canto S. Carranza-Lira J. P. Méndez jpmb@servidor.unam.mx No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Human Reproduction 20 4 2005 965 969
74. C. J. Petry K. K. Ong K. F. Michelmore Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Human Reproduction 20 7 2005 1837 1843
75. C. J. Petry K. K. Ong K. F. Michelmore Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations. Journal of Steroid Biochemistry and Molecular Biology 98 4-5 2006 199 206
76. D. B. Lubahn D. R. Joseph P. M. Sullivan H. F. Willard F. S. French E. M. Wilson Cloning of human androgen receptor complementary DNA and localization to the X chromomose. Science 240 4850 1988 327 330
77. M. A. Carson-Jurica W. T. Schrader B. W. O'Malley Steroid receptor family: structure and functions. Endocrine Reviews 11 2 1990 201 220
78. N. L. Chamberlain E. D. Driver R. L. Miesfeld The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22 15 1994 3181 3186
79. E. Giovannucci M. J. Stampfer K. Krithivas The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 94 7 1997 3320 3323
80. T. G. Tut F. J. Ghadessy M. A. Trifiro L. Pinsky E. L. Yong Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. Journal of Clinical Endocrinology and Metabolism 82 11 1997 3777 3782
81. A. T. Dowsing E. L. Yong M. Clark R. I. McLachlan D. M. De Kretser A. O. Trounson alan.trounson@med.monash.edu.au Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 354 9179 1999 640 643
82. T. R. Rebbeck rebbeck@cceb.med.upenn.edu P. W. Kantoff K. Krithivas Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. American Journal of Human Genetics 64 5 1999 1371 1377
83. A. Mifsud S. Ramirez E. L. Yong Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 85 9 2000 3484 3488
84. T. Hickey A. Chandy R. J. Norman The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 1 2002 161 165
85. J. Jääskeläinen jarmo.jaaskelainen@uku.fi S. Korhonen R. Voutilainen M. Hippeläinen S. Heinonen Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. Fertility and Sterility 83 6 2005 1724 1728
86. M. Pugeat J. C. Crave J. Tourniaire M. G. Forest Clinical utility of sex hormone-binding globulin measurement. Hormone Research 45 3-5 1996 148 155
87. C. Selby Sex hormone binding globulin: origin, function and clinical significance. Annals of Clinical Biochemistry 27, part 6 1990 532 541
88. D. Berube G. E. Seralini R. Gagne G. L. Hammond Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12→p13). Cytogenetics and Cell Genetics 54 1-2 1990 65 67
89. K. N. Hogeveen M. Talikka G. L. Hammond ghammond@uwo.ca Human sex hormone-binding globulin promoter activity is influenced by a ( TAAAA)n repeat element within an Alu sequence. Journal of Biological Chemistry 276 39 2001 36383 36390
90. N. Xita A. Tsatsoulis atsatsou@cc.uoi.gr A. Chatzikyriakidou I. Georgiou Association of the ( TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. Journal of Clinical Endocrinology and Metabolism 88 12 2003 5976 5980
91. P. Cousin L. Calemard-Michel H. Lejeune Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. Journal of Clinical Endocrinology and Metabolism 89 2 2004 917 924
92. A. H. Balen Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Human Reproduction 8, supplement 2 1993 123 128
93. J. E. Hall A. E. Taylor K. A. Martin W. F. Crowley New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome. Annals of the New York Academy of Sciences 687 1993 182 192
94. K. Furui N. Suganuma S.-I. Tsukahara Identification of two point mutations in the gene coding luteinizing hormone (LH) β-subunit, associated with immunologically anomalous LH variants. Journal of Clinical Endocrinology and Metabolism 78 1 1994 107 113
95. C. Nilsson K. Pettersson R. P. Millar K. A. Coerver M. M. Matzuk I. T. Huhtaniemi Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. Fertility and Sterility 67 6 1997 998 1004
96. K. Okuda T. Yamada H. Imoto H. Komatsubara O. Sugimoto Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions. Biochemical and Biophysical Research Communications 200 1 1994 584 590
97. A.-M. Haavisto K. Pettersson M. Bergendahl A. Virkamaki I. Huhtaniemi Occurrence and biological properties of a common genetic variant of luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 80 4 1995 1257 1263
98. M. Rajkhowa J. A. Talbot P. W. Jones Prevalence of an immunological LH β-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clinical Endocrinology 43 3 1995 297 303
99. J. S. Tapanainen R. Koivunen B. C. J. M. Fauser A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 84 5 1999 1711 1715
100. L. N. Ramanujam W. X. Liao A. C. Roy obgroyac@nus.edu.sg A. Loganath H. H. Goh S. C. Ng Association of molecular variants of luteinizing hormone with menstrual disorders. Clinical Endocrinology 51 2 1999 243 246
101. K. Elter C. T. Erel N. Cine U. Ozbek B. Hacihanefioglu E. Ertungealp Role of the mutations Trp8 → Arg and Ile15 → Thr of the human luteinizing hormone β-subunit in women with polycystic ovary syndrome. Fertility and Sterility 71 3 1999 425 430
102. A. C. Roy W.-X. Liao Y. Chen S. Arulkumaran S. S. Ratnam Identification of seven novel mutations in LH β-subunit gene by SSCP. Molecular and Cellular Biochemistry 165 2 1996 151 153
103. K. Takahashi taka27@shimane-med.ac.jp K. Karino H. Kanasaki Influence of missense mutation and silent mutation of LHβ-subunit gene in Japanese patients with ovulatory disorders. European Journal of Human Genetics 11 5 2003 402 408
104. S. Franks N. Gharani M. McCarthy Candidate genes in polycystic ovary syndrome. Human Reproduction Update 7 4 2001 405 410
105. P. G. Knight C. Glister Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction 121 4 2001 503 512
106. Q. Guo T. R. Kumar T. Woodruff L. A. Hadsell F. J. DeMayo M. M. Matzuk mmatzuk@bcm.tmc.edu Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Molecular Endocrinology 12 1 1998 96 106
107. J. P. Mather A. Moore R.-H. Li Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proceedings of the Society for Experimental Biology and Medicine 215 3 1997 209 222
108. H. Shibata M. Kanzaki T. Takeuchi J.-I. Miyazaki I. Kojima Two distinct signaling pathways activated by activin a in glucose-responsive pancreatic β-cell lines. Journal of Molecular Endocrinology 16 3 1996 249 258
109. R. S. Legro R. Spielman M. Urbanek D. Driscoll J. F. Strauss III A. Dunaif Phenotype and genotype in polycystic ovary syndrome. Recent Progress in Hormone Research 53 1998 217 256
110. M. Urbanek X. Wu K. R. Vickery Allelic variants of the follistatin gene in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 85 12 2000 4455 4461
111. W. X. Liao A. C. Roy obgroyac@nus.edu.sg S. C. Ng Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome. Molecular Human Reproduction 6 7 2000 587 590
112. R. M. Calvo G. Villuendas J. Sancho J. L. San Millán H. F. Escobar-Morreale Role of the follistatin gene in women with polycystic ovary syndrome. Fertility and Sterility 75 5 2001 1020 1023
113. A. Dunaif K. R. Segal W. Futterweit A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 9 1989 1165 1174
114. C. Junien V. van Heyningen Report of the committee on the genetic constitution of chromosome 11. Cytogenetics and Cell Genetics 55 1-4 1990 153 169
115. G. C. Kennedy M. S. German W. J. Rutter The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genetics 9 3 1995 293 298
116. J. Paquette N. Giannoukakis C. Polychronakos P. Vafiadis C. Deal dealc@ere.umontreal.ca The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans. Journal of Biological Chemistry 273 23 1998 14158 14164
117. G. I. Bell M. J. Selby W. J. Rutter The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature 295 5844 1982 31 35
118. J. U. Weaver P. G. Kopelman G. A. Hitman Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. European Journal of Clinical Investigation 22 4 1992 265 270
119. K. K. L. Ong D. I. Phillips C. Fall The insulin gene VNTR, type 2 diabetes and birth weight. Nature Genetics 21 3 1999 262 263
120. A. Dunaif K. R. Segal D. R. Shelley G. Green A. Dobrjansky T. Licholai Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41 10 1992 1257 1266
121. J. Holte T. Bergh C. Berne L. Wide H. Lithell Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 80 9 1995 2586 2593
122. N. M. O'Meara J. D. Blackman D. A. Ehrmann Defects in β-cell function in functional ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 76 5 1993 1241 1247
123. D. M. Waterworth S. T. Bennett N. Gharani Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349 9057 1997 986 990
124. I. A. Eaves S. T. Bennett P. Forster Transmission ratio distortion at the INS-IGF2 VNTR. Nature Genetics 22 4 1999 324 325
125. K. Michelmore K. Ong S. Mason Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clinical Endocrinology 55 4 2001 439 446
126. R. M. Calvo D. Tellería J. Sancho J. L. San Millán H. F. Escobar-Morreale Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertility and Sterility 77 4 2002 666 668
127. M. Vanková J. Vrbíková M. Hill O. Cinek B. Bendlová Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Annals of the New York Academy of Sciences 967 2002 558 565
128. J. P. A. Ioannidis jioannid@cc.uoi.gr T. A. Trikalinos E. E. Ntzani D. G. Contopoulos-Ioannidis Genetic associations in large versus small studies: an empirical assessment. Lancet 361 9357 2003 567 571
129. B. L. Powell L. Haddad A. Bennett Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. Journal of Clinical Endocrinology and Metabolism 90 5 2005 2988 2993
130. I. D. Goldfine The insulin receptor: molecular biology and transmembrane signaling. Endocrine Reviews 8 3 1987 235 255
131. L. R. Sorbara Z. Tang A. Cama Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome. Metabolism 43 12 1994 1568 1574
132. G. S. Conway C. Avey G. Rumsby The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome. Human Reproduction 9 9 1994 1681 1683
133. J. A. Talbot E. J. Bicknell M. Rajkhowa A. Krook S. O'Rahilly R. N. Clayton Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 81 5 1996 1979 1983
134. S. Tucci W. Futterweit E. S. Concepcion Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. Journal of Clinical Endocrinology and Metabolism 86 1 2001 446 449
135. G. Villuendas H. F. Escobar-Morreale hector.escobar@uam.es F. Tosi J. Sancho P. Moghetti J. L. San Millán Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertility and Sterility 79 1 2003 219 220
136. M. Urbanek m-urbanek@northwestern.edu A. Woodroffe K. G. Ewens Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. Journal of Clinical Endocrinology and Metabolism 90 12 2005 6623 6629
137. S. Siegel W. Futterweit T. F. Davies A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertility and Sterility 78 6 2002 1240 1243
138. S. R. Hubbard L. Wei L. Ellis W. A. Hendrickson Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372 6508 1994 746 754
139. M. F. White IRS proteins and the common path to diabetes. American Journal of Physiology - Endocrinology and Metabolism 283 3 2002 E413 E422
140. D. J. Burks M. F. White IRS proteins and beta-cell function. Diabetes 50, supplement 1 2001 S140 S145
141. A. Jellema a.jellema@hb.unimaas.nl M. P. A. Zeegers E. J. M. Feskens P. C. Dagnelie R. P. Mensink Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 46 7 2003 990 995
142. T. Sir-Petermann F. Pérez-Bravo B. Angel M. Maliqueo M. Calvillan A. Palomino G972R polymorphism of IRS-1 in women with polycystic ovary syndrome. Diabetologia 44 9 2001 1200 1201
143. S. A. El Mkadem C. Lautier F. Macari Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50 9 2001 2164 2168
144. D. A. Ehrmann X. Tang I. Yoshiuchi N. J. Cox G. I. Bell Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 9 2002 4297 4300
145. G. Villuendas J. I. Botella-Carretero B. Roldán J. Sancho H. F. Escobar-Morreale hescobarm.hrc@salud.madrid.org J. L. San Millán Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls. Human Reproduction 20 11 2005 3184 3191
146. S. Dilek D. Ertunc devrimertunc@hotmail.com E. C. Tok E. M. Erdal A. Aktas Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome. Fertility and Sterility 84 2 2005 407 412
147. D. Ertunc devrimertunc@hotmail.com E. C. Tok A. Aktas E. M. Erdal S. Dilek The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome. Human Reproduction 20 5 2005 1207 1212
148. N. F. Wiernsperger C. J. Bailey The antihyperglycaemic effect of metformin therapeutic and cellular mechanisms. Drugs 58, supplement 1 1999 31 39 discussion 75-82
149. S. K. Sreenan Y.-P. Zhou K. Otani Calpains play a role in insulin secretion and action. Diabetes 50 9 2001 2013 2020
150. Y. Horikawa N. Oda N. J. Cox Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genetics 26 2 2000 163 175
151. D. A. Ehrmann Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus. Baillière's Clinical Obstetrics and Gynaecology 11 2 1997 335 347
152. D. A. Ehrmann P. E. H. Schwarz M. Hara Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 4 2002 1669 1673
153. A. Gonzalez E. Abril A. Roca Comment: CAPN10 alleles are associated with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 8 2002 3971 3976
154. A. Gonzalez alejandro@caf-jerez.com E. Abril A. Roca Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients. Journal of Clinical Endocrinology and Metabolism 88 11 2003 5529 5536
155. L. Haddad J. C. Evans N. Gharani Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 6 2002 2606 2610
156. H. F. Escobar-Morreale B. Peral G. Villuendas R. M. Calvo J. Sancho J. L. San Millán Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertility and Sterility 77 3 2002 581 587
157. E. E. Kershaw ekershaw@bidmc.harvard.edu J. S. Flier jflier@bidmc. harvard.edu Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 89 6 2004 2548 2556
158. L. Oksanen A. Tiitinen J. Kaprio H. A. Koistinen S.-L. Karonen K. Kontula No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome. Molecular Human Reproduction 6 10 2000 873 876
159. F. B. Hu frank.hu@channing.harvard.edu A. Doria T. Li Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53 1 2004 209 213
160. K. Hara P. Boutin Y. Mori Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 2 2002 536 540
161. M. Stumvoll O. Tschritter A. Fritsche Association of the T-G polymorphism in adiponectin (Exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51 1 2002 37 41
162. C. Menzaghi T. Ercolino R. Di Paola A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51 7 2002 2306 2312
163. J. L. San Millán M. Cortón G. Villuendas J. Sancho B. Peral H. F. Escobar-Morreale hescobarm.hrc@salud.madrid.org Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. Journal of Clinical Endocrinology and Metabolism 89 6 2004 2640 2646
164. D. Panidis argic@med.auth.gr A. Kourtis A. Kukuvitis Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Δ 4-androstenedione. Human Reproduction 19 8 2004 1728 1733
165. N. Xita I. Georgiou A. Chatzikyriakidou Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clinical Chemistry 51 2 2005 416 423
166. H. F. Escobar-Morreale hescobarm.hrc@salud.madrid.org G. Villuendas J. I. Botella-Carretero Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Human Reproduction 21 9 2006 2257 2265
167. S. M. Rangwala M. A. Lazar lazar@mail.med.upenn.edu Peroxisome proliferator-activated receptor γ in diabetes and metabolism. Trends in Pharmacological Sciences 25 6 2004 331 336
168. A. Elbrecht alex_elbrecht@merck.com Y. Chen C. A. Cullinan Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochemical and Biophysical Research Communications 224 2 1996 431 437
169. A. J. Vidal-Puig Avidalpu@BIDMC.Harvard.edu R. V. Considine M. Jimenez-Lĩan Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Journal of Clinical Investigation 99 10 1997 2416 2422
170. P. Tontonoz E. Hu R. A. Graves A. I. Budavari B. M. Spiegelman mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 8 10 1994 1224 1234
171. D. Altshuler J. N. Hirschhorn M. Klannemark The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 26 1 2000 76 80
172. A. Dunaif adunaif@med.hmc.psu.edu D. Scott D. Finegood B. Quintana R. Whitcomb The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 81 9 1996 3299 3306
173. R. Azziz D. Ehrmann R. S. Legro Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 86 4 2001 1626 1632
174. G. Ghazeeri W. H. Kutteh M. Bryer-Ash D. Haas R. W. Ke rke@utmem.edu Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertility and Sterility 79 3 2003 562 566
175. A. Meirhaeghe aline.meirhaeghe-hurez@pasteur-lille.fr P. Amouyel Impact of genetic variation of PPARγ in humans. Molecular Genetics and Metabolism 83 1-2 2004 93 102
176. M. Hara S. Y. Alcoser A. Qaadir K. K. Beiswenger N. J. Cox D. A. Ehrmann Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the pparγ gene. Journal of Clinical Endocrinology and Metabolism 87 2 2002 772 775
177. S. Hahn A. Fingerhut U. Khomtsiv The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology 62 5 2005 573 579
178. E. C. Tok A. Aktas D. Ertunc devrimertunc@hotmail.com E. M. Erdal S. Dilek Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-γ2 Pro12Ala genotype. Human Reproduction 20 6 2005 1590 1595
179. S. Korhonen S. Heinonen seppo.heinonen@kuh.fi M. Hiltunen Polymorphism in the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome. Human Reproduction 18 3 2003 540 543
180. M. Yilmaz murartt@hotmail.com M. A. Ergün A. Karakoç Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in first-degree relatives of subjects with polycystic ovary syndrome. Gynecological Endocrinology 21 4 2005 206 210
181. M. Yilmaz murartt@hotmail.com M. A. Ergün A. Karakoç E. Yurtçu N. Çakir M. Arslan Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome. Gynecological Endocrinology 22 6 2006 336 342
182. F. Orio Jr. f.orio@tin.it G. Matarese S. Di Biase Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88 12 2003 5887 5892
183. Y. Wang X. Wu xiaokewu@nju.edu.cn Y. Cao L. Yi H. Fan J. Chen Polymorphisms of the peroxisome proliferator-activated receptor-γ and its coactivator-1α genes in Chinese women with polycystic ovary syndrome. Fertility and Sterility 85 5 2006 1536 1540
184. F. Orio Jr. francescoorio@virgilio.it S. Palomba T. Cascella Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89 10 2004 5110 5115
185. C. R. Milner J. E. Craig N. D. Hussey R. J. Norman No association between the -308 polymorphism in the tumour necrosis favor α (TNFα) promoter region and polycystic ovaries. Molecular Human Reproduction 5 1 1999 5 9
186. W. Mao L. Yu Y. Chen Study on the relationship between a polymorphism of tumor necrosis factor-α gene and the pathogenesis of polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 35 9 2000 536 539
187. S. Korhonen E.-L. Romppanen M. Hiltunen Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-α and polycystic ovary syndrome. Gynecological Endocrinology 16 4 2002 271 274
188. B. Peral J. L. San Millán R. Castello P. Moghetti H. F. Escobar-Morreale Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 87 8 2002 3977 3983
189. M. Möhlig J. Spranger M. Osterhoff The polycystic ovary syndrome per se is not associated with increased chronic inflammation. European Journal of Endocrinology 150 4 2004 525 532
190. H. F. Escobar-Morreale hector.escobar@uam.es R. M. Calvo G. Villuendas J. Sancho J. L. San Millán Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obesity Research 11 8 2003 987 996
191. D. Seto-Young dyoung@chpnet.org M. Paliou J. Schlosser Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. Journal of Clinical Endocrinology and Metabolism 90 11 2005 6099 6105
192. D. Glintborg dorte.glintborg@dadlnet.dk R. K. Støving C. Hagen Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 90 10 2005 5605 5612
193. E. Jansen erik.jansen@organon.com J. S. E. Laven H. B. R. Dommerholt Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Molecular Endocrinology 18 12 2004 3050 3063
194. J. R. Wood V. l. Nelson-Degrave E. Jansen J. M. McAllister S. Mosselman J. F. Strauss III jfs3@mail.med.upenn.edu Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiological Genomics 20 2005 233 243
195. J. M. Fernández-Real uden.jmfernandezreal@htrueta.scs.es W. Ricart Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews 24 3 2003 278 301
196. E. Diamanti-Kandarakis C. Piperi J. Spina Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens, Greece) 5 1 2006 17 34
197. G. S. Hotamisligil P. Peraldi A. Budavari R. Ellis M. F. White B. M. Spiegelman brucespiegelman@dfciharvard.edu IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271 5249 1996 665 668
198. H. F. Escobar-Morreale R. M. Calvo J. Sancho J. L. San Millán TNF-α and hyperandrogenism: a clinical, biochemical, and molecular genetic study. Journal of Clinical Endocrinology and Metabolism 86 8 2001 3761 3767
199. G. Villuendas J. L. San Millán J. Sancho H. F. Escobar-Morreale hector.escobar@uam.es The -597 G → A and -174 G → C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 87 3 2002 1134 1141
200. B. O. Yildiz I. C. Haznedaroǧlu S. Kirazli M. Bayraktar Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. Journal of Clinical Endocrinology and Metabolism 87 8 2002 3871 3875
201. P. Eriksson B. Kallin F. M. Van't Hooft P. Bavenholm A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America 92 6 1995 1851 1855
202. E. Diamanti-Kandarakis akandara@otenet.gr G. Palioniko K. Alexandraki A. Bergiele T. Koutsouba M. Bartzis The prevalence of 4G5G polymorphism of plasminogen activator ihibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. European Journal of Endocrinology 150 6 2004 793 798
203. S. Nayak P. A. Lee S. F. Witchel Variants of the type II 3β-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. Molecular Genetics and Metabolism 64 3 1998 184 192
204. N. Moghrabi I. A. Hughes A. Dunaif S. Andersson andersson@grnctr.swmed. edu Deleterious missense mutations and silent polymorphism in the human 17β-hydroxysteroid dehydrogenase 3 gene (HSD17B3). Journal of Clinical Endocrinology and Metabolism 83 8 1998 2855 2860
205. R. S. Legro D. R. Muhleman D. E. Comings R. A. Lobo B. W. Kovacs A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female hispanics. Fertility and Sterility 63 4 1995 779 784
206. M. Kahsar-Miller L. R. Boots R. Azziz razziz@uabmc.edu Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome. Fertility and Sterility 71 3 1999 436 438
207. S. P. Zhao X. M. Tang D. H. Shao H. Y. Dai S. Z. Dai Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 38 2 2003 94 97
208. M. Rajkhowa J. A. Talbot P. W. Jones R. N. Clayton Polymorphism of glycogen synthetase gene in polycystic ovary syndrome. Clinical Endocrinology 44 1 1996 85 90
209. M. Urbanek Y. Du K. Silander Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 52 1 2003 214 217
210. S. Heinonen S. Korhonen M. Hippelainen M. Hiltunen A. Mannermaa S. Saarikoski Apolipoprotein E alleles in women with polycystic ovary syndrome. Fertility and Sterility 75 5 2001 878 880
211. R. Azziz azzizr@cshs.org PCOS: a diagnostic challenge. Reproductive BioMedicine Online 8 6 2004 644 648
212. D. Gordon gordon@linkage.rockefeller.edu S. J. Finch Factors affecting statistical power in the detection of genetic association. Journal of Clinical Investigation 115 6 2005 1408 1418
213. H. F. Escobar-Morreale hescobarm.hrc@salud.madrid.org M. Luque-Ramírez J. L. San Millán The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews 26 2 2005 251 282
214. M. Garg M. Thamotharan L. Rogers S. Bassilian W. N. P. Lee S. U. Devaskar Glucose metabolic adaptations in the intrauterine growth-restricted adult female rat offspring. American Journal of Physiology - Endocrinology and Metabolism 290 6 2006 E1218 E1226